Natural Product (NP) Details
General Information of the NP (ID: NP7644) | |||||
---|---|---|---|---|---|
Name |
Tephrosin
|
||||
Synonyms |
Tephrosin; hydroxydeguelin; 76-80-2; deguelinol I; UNII-9C081V83CC; CHEBI:9442; 9C081V83CC; (1R,14R)-14-hydroxy-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.03,12.04,9.015,20]docosa-3(12),4(9),5,10,15,17,19-heptaen-13-one; CCRIS 7115; (?)-Tephrosin; (-)-TEPHROSIN; SCHEMBL766277; CHEMBL241806; MEGxp0_001258; DTXSID20878627; HY-N1166; ZINC4098748; BDBM50505206; LMPK12060047; Tephrosin, >=95% (LC/MS-ELSD); MCULE-5773910433; NCGC00347726-02!; CS-0016457; C10535; Q7701343; (7aR,13aR)-13,13a-dihydro-7a-hydroxy-9,10-dimethoxy-3,3-dimethyl-3H-bis(1)benzopyrano(3,4-b:6',5'-e)pyran-7(7aH)-one; (7aR,13aR)-7a-hydroxy-9,10-dimethoxy-3,3-dimethyl-13,13a-dihydro-3H-chromeno[3,4-b]pyrano[2,3-h]chromen-7(7aH)-one; 3H-Bis(1)benzopyrano(3,4-b:6',5'-e)pyran-7(7aH)-one, 13,13a-dihydro-7a-hydroxy-9,10-dimethoxy-3,3-dimethyl-, (7aR,13aR)-; 3H-Bis(1)benzopyrano(3,4-b:6',5'-e)pyran-7(7aH)-one, 13,13a-dihydro-7a-hydroxy-9,10-dimethoxy-3,3-dimethyl-, (7aR-cis)-
Click to Show/Hide
|
||||
Species Origin | Tephrosia vogelii ... | Click to Show/Hide | |||
Tephrosia vogelii | |||||
Disease | Pancreatic cancer [ICD-11: 2C10] | Investigative | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C23H22O7
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1(C=CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4(C3=O)O)OC)OC)C
|
||||
InChI |
1S/C23H22O7/c1-22(2)8-7-12-15(30-22)6-5-13-20(12)29-19-11-28-16-10-18(27-4)17(26-3)9-14(16)23(19,25)21(13)24/h5-10,19,25H,11H2,1-4H3/t19-,23-/m1/s1
|
||||
InChIKey |
AQBZCCQCDWNNJQ-AUSIDOKSSA-N
|
||||
CAS Number |
CAS 76-80-2
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
2-deoxy-D-glucose | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vitro Model | HeLa | CVCL_0030 | Endocervical adenocarcinoma | Homo sapiens | ||
HT-29 | CVCL_0320 | Colon adenocarcinoma | Homo sapiens | |||
SW620 | CVCL_0547 | Colon adenocarcinoma | Homo sapiens | |||
A-549 | CVCL_0023 | Lung adenocarcinoma | Homo sapiens | |||
Experimental
Result(s) |
The combination of TSN and 2-DG increased the sensitivity of cancer cells to 2-DG. |
